V

VERTANICAL

Develops cannabinoid-based therapies for chronic pain

Junior Medical Manager

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeGräfelfing, GermanyNo salary listedHybrid

About the Job

Requirements

  • You have completed medical studies.
  • Ideally, you bring prior experience in clinical research and working with tools and records such as electronic case report forms, electronic diaries, and adverse event reports.
  • You understand data analysis in Excel.
  • You have experience coordinating service providers and investigators.
  • You have attention to detail and analytical thinking.
  • You work precisely and are strongly results-oriented.
  • You can organize yourself and work with limited supervision.
  • You can present your own topics to executives.
  • You have professional-level German and English language skills at least at C1 level.

Responsibilities

  • You are responsible for compliance of clinical trials with statutory safety requirements.
  • You coordinate collaboration with contract research organizations and investigators in the assessment and reporting of adverse events and protocol deviations.
  • You focus on jointly developing safety and medical monitoring plans.
  • You regularly conduct medical-monitoring audits of clinical data to identify potential safety concerns.
  • You contribute to preparing study protocols and patient informed-consent documents.
  • You work with the data management team to ensure safety data is accurately collected, analyzed, and reported.
  • You prepare and review clinical trial plans and annual safety reports.

About the Company

VERTANICAL

Develops cannabinoid-based therapies for chronic pain

VERTANICAL develops therapies for chronic pain. Its lead product, VER-01, is a cannabinoid-based treatment designed to relieve pain and also help with common comorbid problems like sleep disorders and reduced physical function. The company aims to move beyond simple pain relief by addressing multiple related symptoms and to set new standards in pain therapy with VER-01 becoming the leading treatment for chronic pain by 2030. Compared with competitors, VERTANICAL emphasizes a global leadership position through a focused cannabinoid approach and a mission to significantly reduce the burden of chronic pain. The overarching goal is a world free of chronic pain.

Company size
11-50
Company stage
Not listed
Total funding
Not listed
Headquarters
Gräfelfing, Germany
Founded
2017

Recently Posted Jobs

Explore more opportunities at VERTANICAL

See more jobs